PRN: Global Connected Drug Injection Devices Market 2016-2020 - The Rapid Rise of Prefilled Injection Devices

24/mar/2016 18:10:15 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Connected Drug Injection Devices Market 2016-2020 - The Rapid Rise of Prefilled Injection Devices


DUBLIN, March 24, 2016 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Connected Drug Injection Devices" report to their offering.

Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life. Connected devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants.

What You Will Learn

- What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?

- What benefits do connected drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?

- What therapeutic areas are the current focus of connected devices?

- Who are the companies behind the push to connected injection devices? What are their development activities and corporate alliances and affiliations

- What is the importance of pharma-device alliances and design partnerships on connected drug injection device commercialization and market access?

- What does the current market for connected drug injection devices look like? What will it look like in 2020?

- What are the key market drivers for the growth of connected injection devices?

Who Should Read This Report


- Drug Developers - Device Suppliers - CMOs - Components/APIs - Testing/Validation - Clinical Trial Mgmt


- Pharma Managers - Biotech Managers - Drug Marketers - Industry Strategists - Financial Analysts - Management - Consultants


- Clinical Managers - Drug Distributors - Pharma Regulators - FDA Consultants - Managed Care Managers

Key Topics Covered:

1. Executive Summary

2. Connected Devices - The Opportunity

- Injectable Drug Development Trends

- The Rapid Rise of Prefilled Injection Devices

- Factors Driving Drug Self-Administration

- Therapeutic Demand Drivers

- The Impact of Developing Economies

3. Connectivity Technologies - Wireless Technologies - Bluetooth - Cellular - Near Field Communications - Wired Technologies

4. Connected Devices

5. Wearable Devices - Connected Autoinjectors - Non-drug Specific Connected Injectors - Self-powered Devices - Automated Connected Injectors - Vendor-specific Connectivity Platforms

6. Third Party Connectivity Devices

7. Near-term Markets for Connected Injection Devices - Anaphylaxis - Autoimmune Disease - Cardiovascular - Diabetes - Hormone Replacement

8. Market Factors

- Regulatory Requirements

- Data Security

- Patient Acceptance

9. Company Profiles

For more information visit

Media Contact:

Research and Markets

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl